Hypertrophic cardiomyopathy

------------------------------------------------- Hypertrophic cardiomyopathy Hypertrophic cardiomyopathy (HCM) is a primary disease of the myocardium (the muscle of the heart) in which a portion of the myocardium ishypertrophied (thickened) without any obvious cause. It is perhaps best known as a leading cause of sudden cardiac death in young athletes.[7] The occurrence of hypertrophic cardiomyopathy is a significant cause of sudden unexpected cardiac death in any age group and as a cause of disabling

Approximately, 1 of every 500 people is affected with hypertrophic cardiomyopathy, it is important for patients to understand the dynamics of the disease as it could potentially be life threatening. In most cases, the patients quality of life is not affected, but a few will experience symptoms that cause significant discomfort or undetected complications that could lead to sudden cardiac death. With that in mind, it would be beneficial to recognize what it is, specific causes, the steps of diagnoses

“Atrial Fibrillation in Hypertrophic Cardiomyopathy:Diagnosis and Considerations for Management,” discusses the significance of early recognition and treatment of Atrial Fibrillation (AF). In addition, the journal provides information about the role rhythm plays in hypertrophic cardiomyopathy and ventricular arrhythmias. Hypertrophic cardiomyopathy (HCM) is the leading monogenetic cardiomyopathy. HCM has a prevalence of 1:500 (Ali, 2018). Localization and severity of hypertrophy dictate whether

because of its links to sudden death syndrome in young athlete, and to dilated cardiomyopathy (Yilmaz et al., 2012). There are many proposed causes of sudden athlete death; one of the primary causes is hypertrophic cardiomyopathy (HCM). As with any disease we should investigate all factors influencing its pathology including but not limited to: genetic, cultural, and environmental factors. Hypertrophic cardiomyopathy is a heritable disease that is typically passed down as an autosomal dominant trait;

myomectomy) Hypertrophic cardiomyopathy, HCM is a cardiac disorder with a genetic etiology, characterized by hypertrophy of the myocardium It is an important cause of morbidity and mortality in the affected population. Both men and women are affected equally and people of any age and race are at risk of developing HCM. It is the most common cause of sudden cardiac death SCD in young adults, especially athletes. Description of the disorder Hypertrophic cardiomyopathy is characterized

Hypertrophic cardiomyopathy, also known as the disease of the sarcomere, is a common inherited heart disease with a diverse phenotypic and genotypic expression, clinical presentation, and natural history. It is the most common genetic cardiac disease and the first to be associated with a genetic background. It is caused by more than 1,500 mutations in 11 or more genes encoding thick and thin contractile myofilament protein components of the sarcomere, or adjacent Z-disc, which are expressed almost

state which type of cardiomyopathy he had a history of, but there are four types of cardiomyopathies. Dilated cardiomyopathy is when both heart ventricles are dilated and the heart’s pumping function is impaired because the ventricular walls stretch out to very thin widths (Dechant, 2016). Hypertrophic cardiomyopathy is where the walls of the ventricles thicken and grow inwards, and could impair the outflow of blood when the heart contracts (Dechant, 2016). Restrictive cardiomyopathy is when the ventricles

------------------------------------------------- Hypertrophic cardiomyopathy Hypertrophic cardiomyopathy (HCM) is a primary disease of the myocardium (the muscle of the heart) in which a portion of the myocardium ishypertrophied (thickened) without any obvious cause. It is perhaps best known as a leading cause of sudden cardiac death in young athletes.[7] The occurrence of hypertrophic cardiomyopathy is a significant cause of sudden unexpected cardiac death in any age group and as a cause of disabling

Despite the absence of a cure or preventative measures for Hypertrophic Cardiomyopathy, there have been notable advances in both diagnostic techniques and successful treatments available. Hypertrophic Cardiomyopathy is also known as HCM. It is a genetic condition in which the myocardium or heart muscle in the left ventricle is thickened. HCM cannot be identified by a single complaint or symptom as it is different for every person that it affects. This disease not only causes left ventricle hypertrophy

on Hypertrophic Cardiomyopathy, specifically focusing on the pediatric population, and even more narrowing on athletes. This is a growing area of concern in the medical field due to the undetected Hypertrophic Cardiomyopathy in athletes until a Sudden Cardiac Death (SCD). Shockingly many athletes are instantly dying on the soccer field and basketball courts not even aware there is a cardiac issue until it is too late. The following paragraphs will explore what is Hypertrophic Cardiomyopathy, who